fluoroscopy

(redirected from Fluoroscopic procedure)
Also found in: Dictionary, Thesaurus, Medical.
Related to Fluoroscopic procedure: Flouroscope

fluoroscopy

examination of a person or object by means of a fluoroscope

fluoroscopy

[flu̇′räs·kə·pē]
(engineering)
Use of a fluoroscope for x-ray examination.
References in periodicals archive ?
Food and Drug Administration (FDA) entered the picture, issuing public health advisories dealing with serious radiation-related skin injuries resulting from some fluoroscopic procedures.
Our goal is to ensure that every facility uses appropriate dose reduction techniques when performing fluoroscopic procedures, said Donald Peck, PhD, American Association of Physicists in Medicine (AAPM) representative to Image Wisely.
Credentialing to perform fluoroscopic procedures should include documented training in radiation.
The document also identified specific high-dose fluoroscopic procedures that could be harmful and reinforced the SMDA requirement to report injuries to the CDRH.
The radiolucent top, which permits AP and lateral imaging, supplies 58" imaging coverage and panning capability with 10" longitudinal movement, while the Procedural Stretcher's generous 48' x 34" frame opening easily accommodates a C-Arm for fluoroscopic procedures.
Features include the latest EPS-Plus Digital Imaging System -- an all-digital processing system designed to shorten exam times and reduce the costs of film, handling and storage associated with conventional R&F fluoroscopic procedures.
In addition to the matters described above, the ability of the Company to develop its products, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of AngioDynamics, Inc.
In addition to performing fluoroscopic procedures, technologists also have been trained to place an enterostomy tube into the proximal small bowel for enteroclysis examination with an overall success rate of 92%.
In addition to the matters described above, the ability of the Company to develop its products, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, and competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of AngioDynamics, Inc.
With products used in almost 4,000 hospitals, Eigen's digital solutions are part of a wide range of cardiovascular imaging and fluoroscopic procedures.
In addition to the matters described above, the ability of the Company to develop its products, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc.
In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the VenaCure(TM) Laser Vein Treatment System, results of the pending patent litigation with Diomed, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of AngioDynamics Inc.